Kibupea 30 Tablets

Kibupea: the specific supplement for intestinal health in functional disorders

Irritable bowel syndrome (IBS) is a common chronic condition affecting millions of people and manifests itself with debilitating symptoms such as bloating, abdominal pain, constipation, and diarrhea . Kibupea was created to offer a concrete and natural solution to these intestinal problems.

Kibupea is a dietary supplement in tablet form formulated to offer targeted support in managing intestinal symptoms associated with irritable bowel syndrome. Its innovative composition, combining Palmitoylethanolamide (PEA), Sodium Butyrate, and Chios Mastic , is designed to act on multiple fronts: inflammation, intestinal mucosal integrity, and motility.

PEA is an endogenous lipid belonging to the amide fatty acid family, known for its anti-inflammatory and neuroprotective properties . It acts as a modulator of mast cells and astrocytes , reducing cellular activation and the resulting production of pro-inflammatory mediators. In the context of inflammatory bowel disease, where neurogenic inflammation and intestinal barrier dysfunction play a key role, PEA helps reduce visceral pain and abdominal discomfort, improving the patient's quality of life.

Butyrate is a short-chain fatty acid (SCFA) naturally produced by the intestinal microbiota during fiber fermentation. Sodium butyrate , in its microencapsulated form, acts as the main energy substrate for colonocytes , promoting the regeneration of the intestinal epithelium and the restoration of the mucosal barrier . Furthermore, it has antioxidant, anti-inflammatory , and immunomodulatory effects , useful for containing altered intestinal permeability, common in subjects affected by .

The natural resin extracted from Pistacia lentiscus , known as Chios Mastic , is traditionally used for its antibacterial, anti-inflammatory, and gastroprotective properties . Studies have highlighted its effectiveness in modulating the intestinal microbiota and counteracting the growth of opportunistic pathogens such as Helicobacter pylori . In Kibupea, its presence is aimed at normalizing intestinal transit , countering dysbiosis, and reducing abdominal bloating.

Why choose Kibupea?

• Targeted multifactorial actionThe combination of PEA, sodium butyrate, and Chios mastic acts on inflammation, intestinal permeability, and dysbiosis, addressing the root causes of irritable bowel syndrome.
• Natural support and high tolerabilityAll active ingredients are natural and well tolerated, even by those with sensitive or reactive intestinal mucosa. The absence of aggressive excipients makes it suitable for prolonged use.
• Reduction of functional intestinal symptomsRegular use of Kibupea can help reduce bloating, abdominal pain, alternating diarrhea, and constipation, improving daily intestinal comfort.
• Advanced formulation technologyThe tablets are designed to ensure stability and bioavailability of the active ingredients, facilitating administration and improving the effectiveness of their action.
• Thanks to his tolerability and synergistic nature of its components, Kibupea can also be used for long periods, as ongoing support to intestinal function in subjects predisposed to recurrent disorders.

KIBUPEA MEDIA ANALYSIS AND INGREDIENTS

AVERAGE ANALYSIS FOR 3 TABLETS:

INGREDIENTS
Ingredients: bulking agent: microcrystalline cellulose; PEA (Palmitoylethanolamide), Sodium
Butyrate, Chios mastic (Pistacia Lentiscus L, resin); anti-caking agents: dibasic calcium phosphate, talc, magnesium stearate, colloidal anhydrous silica; coating agents: Sodium alginate, Glycerol, Polyethylene glycol, Stearic acid, Ammonium hydroxide, shellac.